ASSET CONTRIBUTION AGREEMENT concerning the assets, rights, liabilities and obligations of Forward Pharma A/SAsset Contribution Agreement • September 26th, 2017 • Forward Pharma a/S • Pharmaceutical preparations
IPR SERVICES, ADMINISTRATION, FUNDING AND NOVATION AGREEMENTSettlement and License Agreement • September 26th, 2017 • Forward Pharma a/S • Pharmaceutical preparations • New York
This IPR SERVICES, ADMINISTRATION, FUNDING AND NOVATION AGREEMENT (this “Agreement”), effective as of June 30, 2017, is made and entered into between Forward Pharma A/S, a Danish limited liability company (“Forward Pharma”), Forward Pharma Operations ApS, a Danish limited liability company and wholly owned direct subsidiary of Forward Pharma (“New SubCo”), FWP IP ApS, a Danish limited liability company and wholly owned direct subsidiary of New SubCo (“SubCo 1”), Biogen Swiss Manufacturing GmbH, a Swiss limited liability company (“U.S. Licensee”) and Biogen International Holding Limited, a Bermudan private limited company (“Designated Countries Licensee” and together with the U.S. Licensee, “Licensee” and each of the foregoing, a “Party” and collectively, the “Parties” hereunder). Capitalized terms used and not defined in the body of this Agreement shall have the meaning ascribed in the License Agreement (as defined below).
